NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmnovo AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/06 | 2021/06 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
948
|
76
|
0 |
Earnings before taxes |
-46,246
|
-18,498
|
-9,735 |
EBITDA |
-45,361
|
-18,396
|
-9,708 |
Total assets |
16,193
|
18,833
|
7,344 |
Current assets |
16,134
|
18,750
|
7,229 |
Current liabilities |
2,339
|
1,812
|
2,000 |
Equity capital |
13,825
|
16,990
|
5,308 |
- share capital |
278
|
238
|
156 |
Employees (average) |
3
|
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/06 | 2021/06 |
Solvency |
85.4%
|
90.2%
|
72.3% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-279.7%
|
-97.8%
|
-132.6% |
Current ratio |
689.8%
|
1034.8%
|
361.4% |
Return on equity (ROE) |
-334.5%
|
-108.9%
|
-183.4% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
2
|
0
![]() |
0 |
Chg. No. of employees % |
200%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.